1 – 50 of 309
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
2024) In Movement Disorders Clinical Practice(
- Contribution to journal › Article
-
Mark
Facing and dealing with emotional turbulence : Living with newly diagnosed Parkinson's disease
2024) In Scandinavian Journal of Caring Sciences(
- Contribution to journal › Article
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
(
- Contribution to journal › Article
-
Mark
Forced LMX1A expression induces dorsal neural fates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Immune Mechanisms in Parkinson's Disease and Epilepsy. Preclinical Findings and Clinical Perspectives.
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
- 2023
-
Mark
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers
(
- Contribution to journal › Article
-
Mark
Embracing Monogenic Parkinson's Disease : The MJFF Global Genetic PD Cohort
(
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
(
- Contribution to journal › Article
-
Mark
The Relationship between PDQ-8 and Costs in Parkinson's Disease—A Swedish Register-Based Study
(
- Contribution to journal › Article
-
Mark
Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health-Related Quality of Life
(
- Contribution to journal › Article
-
Mark
Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The etiology of Parkinson's disease. Genetic and non-genetic risk factors for a multifactorial disease
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Restorative cell and gene therapies for Parkinson's disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Parkinsonism in Genetic Neurodevelopmental Disorders : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Ganglioside GM3 stimulates lipid-protein co-assembly in α-synuclein amyloid formation
(
- Contribution to journal › Article
-
Mark
α-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression
(
- Contribution to journal › Article
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
(
- Contribution to journal › Article
-
Mark
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease
2023) In European Journal of Neurology(
- Contribution to journal › Article
-
Mark
Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
(
- Contribution to journal › Article
-
Mark
A Paradigm Shift in the Management of Patients with Parkinson's Disease
(
- Contribution to journal › Scientific review
- 2022
-
Mark
RIC3 variants are not associated with Parkinson's disease in large European, Latin American, or East Asian cohorts
(
- Contribution to journal › Article
-
Mark
A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants
(
- Contribution to journal › Article
-
Mark
Objective and subjective aspects related to walking in people with neurodegenerative disorders
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests
(
- Contribution to journal › Article
-
Mark
Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data
(
- Contribution to journal › Article
-
Mark
The Neuroinflammatory Acute Phase Response in Parkinsonian-Related Disorders
(
- Contribution to journal › Article
-
Mark
Complex modulation of cytokine-induced α-synuclein aggregation by glypican-1-derived heparan sulfate in neural cells
(
- Contribution to journal › Article
-
Mark
Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Ferroptosis in Parkinson's disease : glia–neuron crosstalk
(
- Contribution to journal › Scientific review
-
Mark
A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells
(
- Contribution to journal › Article
-
Mark
Diagnostic work up : Laboratory and biomarkers
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits
(
- Contribution to journal › Article
-
Mark
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep : Results from a Meta-Analysis with 24-Month Follow-Up
(
- Contribution to journal › Scientific review
-
Mark
Inflammatory Animal Models of Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease : Long-Term Observation and Implications of Clinical Subtypes
(
- Contribution to journal › Article
-
Mark
Midsagittal corpus callosal thickness and cognitive impairment in Parkinson's disease
(
- Contribution to journal › Article
- 2021
-
Mark
Exploring Patient-Specific Cell Replacement Therapy for Parkinson's Disease
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Evaluation of TH-Cre knock-in cell lines for detection and specific targeting of stem cell-derived dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Bringing Advanced Therapies for Parkinson's Disease to the Clinic : An Analysis of Ethical Issues
(
- Contribution to journal › Scientific review
-
Mark
Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral Vectors
(
- Contribution to journal › Scientific review
-
Mark
Prognostic subtypes in Parkinson’s disease and related disorders. Clinical, genetical, and biochemical markers for long-term social, motor, and cognitive development.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease : A Structured Review
(
- Contribution to journal › Scientific review
-
Mark
TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
(
- Contribution to journal › Article
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
(
- Contribution to journal › Article